• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ginekol Pol . COVID-19 in pregnancy, management and outcomes among pregnant women and neonates - results from tertiary care center in Wroclaw

tetano

Editor, Senior Moderator
Ginekol Pol


. 2022 Jan 24.
doi: 10.5603/GP.a2021.0201. Online ahead of print.
COVID-19 in pregnancy, management and outcomes among pregnant women and neonates - results from tertiary care center in Wroclaw


Paulina Szczygiol[SUP] 1 [/SUP], Karolina Baranska[SUP] 2 [/SUP], Ilona Korczak[SUP] 2 [/SUP], Aleksandra Zimmer-Stelmach[SUP] 3 [/SUP], Anna Rosner-Tenerowicz[SUP] 3 [/SUP], Mariusz Zimmer[SUP] 3 [/SUP], Barbara Krolak-Olejnik[SUP] 2 [/SUP]



Affiliations

Abstract

Objectives: A novel coronavirus - SARS CoV-2 - outbreak has, for sure, been the greatest medical challenge in recent years. The maternal and neonatal consequences of the infection are still largely unknown.
Material and methods: This prospective study aims to describe the perinatal care and outcomes of SARS-CoV-2 positive pregnant women and their newborn infants during the third wave of the pandemic, in a large tertiary university center in Wroclaw/Poland from 15 February to 1 May 2021.
Results: The paper describes a group of 83 women with confirmed SARS-CoV-2 infection during delivery, as well as their newborn infants (n = 84). The course of COVID-19 disease in pregnant patients was mostly asymptomatic (56%) but 31% women manifested mild to moderate symptoms and 14% had severe infection. The median gestational age at the delivery was 38 weeks. On average, 16.7% of mothers were separated from their newborns at birth, 83.3% practiced skin-to-skin, and roomed in with their babies, and 84.5% of the infants received any mother'smilk. Preterm infants were more often borne by mothers with symptomatic course of COVID-19 infection. Need for neonatal treatment was only due to prematurity. Neonates with acquired infection (after 14th day of life) had to be treated symptomatically with fever and loose stools, only 28.5% had symptoms of respiratory failure.
Conclusions: Despite the confirmed SARS-CoV-2 infection, the majority of mother- infant dyads were in a good health condition. The data on perinatal care reported in the paper could be helpful contribution supporting childbirth physiology protection during the COVID-19 pandemic.

Keywords: COVID-19; SARS-CoV-2; neonate; perinatal care; pregnancy outcomes.
 
Back
Top Bottom